Home/Arvinas/Craig M. Crews
CM

Craig M. Crews

Founder, Professor at Yale University, Executive Director of Yale Center for Molecular Discovery

Arvinas

Therapeutic Areas

Arvinas Pipeline

DrugIndicationPhase
Vepdegestrant (ARV-471)ER+/HER2- Advanced Breast CancerPhase 3
Bavdegalutamide (ARV-110)Prostate CancerPhase 2
ARV-766Prostate CancerPhase 2
ARV-102Parkinson's DiseasePhase 1
ARV-393LymphomaPhase 1
ARV-6723Solid MalignanciesPhase 1
ARV-806Pancreatic CancerPhase 1
ARV-027Breast CancerPhase 1